FDA advisers to weigh cancer blood test
The FDA’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will meet Sept. 23 to discuss and vote on Grail’s premarket approval application for its Galleri blood test, according to a notice published Aug. 10 in the Federal Register. Several health systems, including Renton, Wash.-based Providence and St. Louis-based Mercy, have already […] The post FDA advisers to weigh cancer blood test appeared first on Becker's Hospital Review | Healthcare...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.